Mirati Therapeutics, Inc. announced changes to their executive management team, effective immediately. Daniel R. Faga was appointed as Executive Vice President, Chief Operating Officer and will report directly to Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer. He will be responsible for a broad range of operational areas including but not limited to corporate strategy, finance, legal, program management and investor relations & corporate affairs. Benjamin J. Hickey was appointed as Executive Vice President, Chief Commercial Officer and will report directly to Dr. Baum. His responsibilities will include all aspects of global launch readiness and brand strategy including, sales and marketing, pricing and access, medical affairs, forecasting and analytics, portfolio planning and patient advocacy. Vickie S. Reed was promoted to Senior Vice President, Finance and Chief Accounting Officer. Vickie has been with Mirati for six years and has worked in roles of increasing responsibility during that time. Jessica M. Corson was promoted to Vice President, Business Development. Jessica has been with Mirati for seven years and has worked in roles of increasing responsibility.